@peterdkramer Profile picture
Author of Listening to Prozac, now in new 30th anniversary edition Latest: Death of the Great Man: A Novel Please now follow at: @peterdkramer.bsky.social
Nov 21 12 tweets 3 min read
It's been 19 years since the FDA required a black-box warning on product labels & advertising, alerting doctors & patients that antidepressants can cause suicidality in teens. A new compilation of research finds that the action caused a dramatic increase in deaths by suicide. 2/ Here's the relevant graph. It's stunning. You almost never see public health interventions that cause an inflection point, a dramatic worsening of public health. The red line shows a steady decrease in teen suicides followed, after the warning, with a steady increase. Image
Jun 6 10 tweets 2 min read
2/ Here's the link to the full study: thelancet.com/journals/lanps… 3/ The rate of serious withdrawal syndromes is something under 3%, with most of the problems related to imipramine, paroxetine, & [des]venlafaxine. Sertraline & fluoxetine trials showed severe withdrawal syndromes only rarely.
Sep 30, 2021 10 tweets 3 min read
1/ New study, important enough to appear in the @NEJM, seems to show that, even for primary care patients, staying on antidepressants prevents relapse.
~40% of patients tapered off antidepressants decided to go back on within the following year.
But...

nejm.org/doi/full/10.10… 2/ The research did not include patient with first episodes of depression who were tapered after doing well for 9 months or a year—the old standard of practice. Those patients may, indeed, continue to do well. Only patients w multiple episodes or long usage were studied.
Sep 29, 2021 6 tweets 2 min read
Suicidal behavior peaks in the month *before* meds are prescribed and lessens each month after.
Important paper, looking at a large population, that emphasizes the need to think about who receives a treatment before attributing subsequent adverse results to the treatment. This fallacy, confounding by indication, is rife in discussions of antidepressants. Consider this paper in which the rate of falls in nursing home patients was highest four days before a psychotherapeutic med was prescribed. bmcgeriatr.biomedcentral.com/articles/10.11…
Sep 12, 2021 4 tweets 1 min read
1/ This scandal—misuse of the diagnosis 'schizophrenia' to hide the use of high-risk drugs in the elderly—is a crisis for psychiatry. We need to speak out—and demand the disciplining of doctors who misdiagnose to hide understaffing.
nytimes.com/2021/09/11/hea… 2/ That said, the scandal appears to arise from well-intentioned policy-making. You don't want to punish nursing homes that admit residents with mental illnesses or neurological disorders. Changing the metrics will only risk further unintended problems.
Feb 13, 2019 4 tweets 3 min read
@NYTObits writes of John Gunderson: "He was adamant over the years that psychiatric drugs did not help resolve #borderline symptoms." nyti.ms/2E6UmHv This statement is narrowly true. In lectures, he specified circumstances that warrant the use of a range of medications... 6 months ago, while arguing against widespread use of lamotrigine in #BPD, Gunderson wrote, "Clinical experience has shown that medications can help build an alliance, can relieve states of distress, and can sometimes be helpful for comorbid disorders." ajp.psychiatryonline.org/doi/10.1176/ap…
Jan 27, 2019 7 tweets 3 min read
1/ Thread: New study forthcoming on whether #gene-testing can help guide #antidepressant selection for #depressed patients who have failed to respond to 1 or (on average) 3-4 trials of medication. bit.ly/2LQU75I I have been skeptical: mostly, scant added value… 2/ & I found the reporting of this study annoying. On the primary endpoint, improvement in average #depression rating scores, the gene-testing failed. Patients whose MDs chose new meds w/o help of gene tests did just as well—& yet news reports suggested that tests can help…
Jul 25, 2018 7 tweets 3 min read
1/ Important study on #antidepressants & #heartdisease. 6 months of Rx for even minor depression in #cardiac patients offers protection against adverse events (heart attack, death, etc) seen for many (8+) years out. bit.ly/2LBZPuM @JAMA_current # of interesting points... 2/ The effects of meds on mood were the same as those in many other studies, 2-3 points difference on symptoms, NNT to remission between 5 & 6, effect size under .4 …& this difference, often dismissed as minor, was associated with marked benefits in terms of overall health...